Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -217.12% | 68.33% | -589.05% | -68.78% | 118.17% |
| Total Depreciation and Amortization | 86.94% | 50.47% | 9.03% | -9.14% | 30.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 152.72% | -81.03% | 1,654.67% | 368.04% | -232.53% |
| Change in Net Operating Assets | 27.83% | 232.60% | -1,255.96% | -178.25% | -321.68% |
| Cash from Operations | 85.12% | 137.99% | -689.95% | -768.60% | 14.22% |
| Capital Expenditure | -421.24% | -142.37% | -169.94% | 67.94% | 45.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 861.01% | -104.53% | 77.42% | 166.33% | -120.77% |
| Cash from Investing | 826.39% | -106.08% | 76.21% | 164.78% | -121.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.36% | 48.28% | -8.88% | -2.51% | -401.97% |
| Issuance of Common Stock | -47.02% | -76.48% | -87.09% | -9.13% | -5.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.47% | -84.22% | -203.66% | -19.74% | -135.78% |
| Foreign Exchange rate Adjustments | -12.58% | 441.41% | 49,244.44% | 508.16% | -257.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 461.06% | -95.23% | 74.85% | 140.76% | -154.91% |